tweenvest

Symbiotec Pharmalab Limited (NSEI: SYMBIOTEC)

Health Care · Pharmaceuticals · IN

Rs1,600.60

+1.72% today · +45.8% 1Y

Public summary
A free snapshot of Symbiotec Pharmalab Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Symbiotec Pharmalab Limited (NSEI: SYMBIOTEC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.10B.

Over the last twelve months the share price has gained 45.8%, trading between 934.20 and 1.64K.

Tweenvest scores Symbiotec Pharmalab Limited across four factors: quality 75/100, value 31/100. Its strongest factor is quality.

SYMBIOTEC price history

Sep 4, 2026 · 1,078.25Weekly closes 1,003.35 – 1,611.30Nov 17, 2026 · 1,600.60

Key figures

Market cap
$1.10B
Revenue (TTM)
$101.01M
P/E
77.57
EPS
20.67
Dividend yield
—
Beta (5Y)
—
52-week high
Rs1,642.40
52-week low
Rs934.20
Avg volume (3M)
—
Shares outstanding
64.26M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Vetoquinol SAENXTPA: VETO$1.10B€86.30-0.12%
Guilin Sanjin Pharmaceutical Co., Ltd.SZSE: 002275$1.10BCN¥12.46-3.56%
ST Pharm Co.,Ltd.KOSDAQ: A237690$1.10B₩70,200.00-1.13%
Jiangxi Fushine Pharmaceutical Co., Ltd.SZSE: 300497$1.10BCN¥13.60-2.44%
Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091$1.09BCN¥35.57-3.81%
Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789$1.08BCN¥6.88-1.85%
Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116$1.07BCN¥17.78-1.22%
Beijing Foyou Pharma CO.,LTDSHSE: 601089$1.05BCN¥15.01-0.07%

Browse every Pharmaceuticals company →